CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-18 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −2,123 | $31.58 | $67K | 270,909 |
| 2024-03-18 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −2,914 | $31.58 | $92K | 139,553 |
| 2024-03-18 | GOLDSMITH MARK A See Remarks | Sale 10b5-1 | −5,788 | $31.58 | $183K | 460,379 |
| 2024-03-18 | Anders Jack Chief Financial Officer | Sale 10b5-1 | −1,261 | $31.58 | $40K | 101,959 |
| 2024-03-12 | Horn Margaret A Chief Operating Officer | Option exercise 10b5-1 | +7,936 | $4.09 | $32K | 150,403 |
| 2024-03-12 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −7,936 | $34.07 | $270K | 142,467 |
| 2024-03-12 | Horn Margaret A Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,936 | 44,631 | ||
| 2024-03-11 | Horn Margaret A Chief Operating Officer | Option exercise 10b5-1 | +15,735 | $4.09 | $64K | 158,202 |
| 2024-03-11 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −15,735 | $34.02 | $535K | 142,467 |
| 2024-03-11 | Horn Margaret A Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,735 | 52,567 | ||
| 2024-03-01 | Horn Margaret A Chief Operating Officer | Grant or award | +41,000 | 142,467 | ||
| 2024-03-01 | Horn Margaret A Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +143,500 | 143,500 | ||
| 2024-03-01 | GOLDSMITH MARK A See Remarks | Grant or award | −90,000 | 466,167 | ||
| 2024-03-01 | GOLDSMITH MARK A See Remarks | Grant or award · Stock Option (Right to Buy) | +314,000 | 314,000 | ||
| 2024-03-01 | Cislini Jeff General Counsel | Grant or award | +21,000 | 57,126 | ||
| 2024-03-01 | Cislini Jeff General Counsel | Grant or award · Stock Option (Right to Buy) | +73,500 | 73,500 | ||
| 2024-03-01 | Kelsey Stephen Michael See Remarks | Grant or award | +51,400 | 273,032 | ||
| 2024-03-01 | Kelsey Stephen Michael See Remarks | Grant or award · Stock Option (Right to Buy) | +179,900 | 179,900 | ||
| 2024-03-01 | Anders Jack Chief Financial Officer | Grant or award | +26,400 | 103,220 | ||
| 2024-03-01 | Anders Jack Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +92,400 | 92,400 |
Page 27 of 29 · 569 trades